Fresenius enters into agreement with Galenica pharma to develop new IV iron products. PDF Print
Genetic Engineering News: Fresenius Medical Care and Galenica are establishing a new pharmaceutical company focused on the renal disease segment. To be called Vifor-Fresenius Medical Care Renal Pharma, the company will develop and distribute on a worldwide basis products to treat iron deficiency anemia and bone mineral metabolism for predialysis and dialysis patients.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.